Pipeline
Three chronic-pain programs advancing toward a new era of non-opioid therapeutics.
Neomera is advancing a focused pipeline of best-in-class and first-in-class therapeutic candidates for chronic pain. Built on our proprietary data engine, these programs aim to deliver safer, more effective, and longer-lasting relief.
The need is urgent
1.5B
people live with chronic pain every day — more than cancer and diabetes combined.
Our In-house Pipeline
01
Lead
Peripheral Neuropathic Pain
NaV1.7 / 1.8 / 1.9
oral peptide inhibitor
Lead series identified · hit optimization underway
02
Lead
CNS-Associated Pain
Selective GPCR inhibitor
03
Lead
Inflammatory Pain
